![Paul T Parker](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3053904/0c834713-cb12-47fc-9469-228968f5aee6/profile.png)
Paul T Parker
USA Guide 2024
Band 2 : Intellectual Property
Email address
[email protected]Contact number
+1.206.359.3258Share profile
Band 2
About
Provided by Paul T Parker
Practice Areas
Patent Prosecution & Portfolio Counseling
Intellectual Property Law
Family Office Services
Biotechnology & Pharmaceutical
Semiconductor
Clean Technology
Medical Device
Internet of Things (IoT)
Career
Paul has extensive experience in portfolio development and strategies, landscape analyses, reexaminations, intellectual property due diligence, expert opinions, post-grant procedures, litigation support, and technology transfers. His practice focuses on medical device and semiconductor technologies. In medical devices, he has particular experience in renal neuromodulation; neurovascular aneurysms; spinal cord stimulation; stents, grafts, valves, thrombectomy and embolic treatments; diagnostic and therapeutic ultrasound; spinal stabilization and disc replacement; accommodating intraocular lenses; and aesthetic treatments. In 2015 and 2016, he was involved in acquisitions of emerging medical device companies totaling over $600,000,000.
Discover other Lawyers at
Perkins Coie LLP
Alaska
![Eric B Fjelstad](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3283160/d4fc1371-e121-4240-9d8e-60ae7d5bc906/profile.png)
![Cameron Leonard](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3091395/50681be1-cc50-4cc9-9c72-28fccff43640/profile.png)
![Elena Romerdahl](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3293530/63a1b3de-248d-4869-8b96-3a1c5fe70484/profile.png)
Arizona
![Paul F Eckstein](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3101795/eee6a5e0-6a17-40c8-8707-2fce466e47bd/profile.png)
![Joseph E Mais](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3298252/21aae548-39ab-4150-bbb1-f7d7ded79ae6/profile.png)
![Jessica Everett-Garcia](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3298346/8a0379f3-85a8-45c2-815e-0603887e59d4/profile.png)
![Jordan Green](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3101796/cf881f07-ec9f-4245-8c8d-b1407633275f/profile.png)
![Jean-Jacques Cabou](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3298275/e4da180d-bd9b-40cb-b81e-c0625a1e5767/profile.png)
![Alexis E. Danneman](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3096391/79d0bb90-6df6-4217-8855-7d4f88d56f93/profile.png)
![Thomas Ryerson](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3298318/caf71ed9-f26c-4201-9663-abbe19a980df/profile.png)